Live Breaking News & Updates on D molecular therapeutics inc

Stay informed with the latest breaking news from D molecular therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in D molecular therapeutics inc and stay connected to the pulse of your community

Bfsg LLC Takes Position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)

Bfsg LLC acquired a new stake in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 1,500 shares of the company’s stock, valued at approximately $30,000. A number of other hedge funds have also recently modified their holdings of FDMT. RA Capital Management L.P. boosted […]

United-states , Canada , Dekabank-deutsche-girozentrale , Scott-bizily , David-kirn , Goldman-sachs-group , Nasdaq , Vontobel-holding-ltd , Royal-bank , Barclays , Holdings-channel , Panagora-asset-management-inc

Bfsg LLC Acquires New Position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)

Bfsg LLC acquired a new stake in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,500 shares of the company’s stock, valued at approximately $30,000. A number of other institutional investors and hedge funds […]

United-states , David-kirn , Scott-bizily , Panagora-asset-management-inc , Mt-bank-corp , Nasdaq , T-bank-corp , Sg-americas-securities , D-molecular-therapeutics-inc , Jefferies-financial-group , Goldman-sachs-group , York-mellon-corp

4D Molecular Therapeutics (NASDAQ:FDMT) Trading Down 2.9%

4D Molecular Therapeutics (NASDAQ:FDMT) Trading Down 2.9%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , China , Robert-young-kim , Scott-bizily , Nasdaq , Principal-financial-group-inc , Jefferies-financial-group , Barclays , Allspring-global-investments-holdings , Daiwa-securities-group-inc , China-universal-asset-management-co

4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 2.9%

4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 2.9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Wellington , New-zealand-general- , New-zealand , Robert-young-kim , Scott-bizily , Nasdaq , Jefferies-financial-group , Mirae-asset-global-investments-co , Royal-bank , D-molecular-therapeutics-inc

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Insider Sells $45,045.00 in Stock

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Insider Sells $45,045.00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Scott-bizily , Barclays , Royal-bank , Nasdaq , Goldman-sachs-group , Securities-exchange-commission , International-assets-investment-management , D-molecular-therapeutics-inc , Us-bancorp , D-molecular-therapeutics-company-profile

Royal Bank of Canada Boosts 4D Molecular Therapeutics (NASDAQ:FDMT) Price Target to $40.00

4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its price target boosted by Royal Bank of Canada from $35.00 to $40.00 in a research report released on Monday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. A number of other equities research analysts have also issued reports on […]

Canada , United-states , David-kirn , Scott-bizily , Us-bancorp , Jefferies-financial-group , Ensign-peak-advisors-inc , Goldman-sachs-group , D-molecular-therapeutics-inc , International-assets-investment-management , Lazard-asset-management , Barclays

4D Molecular Therapeutics (NASDAQ:FDMT) Stock Price Down 2.3%

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) dropped 2.3% on Wednesday . The company traded as low as $26.13 and last traded at $26.13. Approximately 43,923 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 1,080,685 shares. The stock had previously closed at $26.75. Wall Street […]

United-states , Wellington , New-zealand-general- , New-zealand , Scott-bizily , David-kirn , D-molecular-therapeutics-inc , Barclays , Nasdaq , Allspring-global-investments-holdings , Goldman-sachs-group , Goldman-sachs-group-inc

4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 2.3%

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) were down 2.3% during trading on Wednesday . The company traded as low as $26.13 and last traded at $26.13. Approximately 43,923 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 1,080,685 shares. The stock had previously […]

Blackrock , Nova-scotia , Canada , United-states , Scott-bizily , David-kirn , Barclays , Novo-holdings , Securities-exchange-commission , Nasdaq , D-molecular-therapeutics-inc , Blackrock-inc

4D Molecular Therapeutics (NASDAQ:FDMT) Now Covered by Barclays

4D Molecular Therapeutics (NASDAQ:FDMT) Now Covered by Barclays
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , David-kirn , Robert-young-kim , Us-bancorp , Royal-bank , International-assets-investment-management , Securities-exchange-commission , Ensign-peak-advisors-inc , Goldman-sachs-group , D-molecular-therapeutics-inc , Lazard-asset-management

Form Bio Establishes Scientific Advisory Board, Comprised of Renowned Experts in Cell and Gene Therapy, for Advancing AI-Driven Therapies

Form Bio Establishes Scientific Advisory Board, Comprised of Renowned Experts in Cell and Gene Therapy, for Advancing AI-Driven Therapies
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

California , United-states , Dallas , Texas , Delhi , India , Peking , Beijing , China , Tokyo , Japan , San-francisco